Ohmatsu H - Search Results

1

Severe interstitial lung disease associated with amrubicin treatment.

Yoh K, Kenmotsu H, Yamaguchi Y, Kubota K, Ohmatsu H, Goto K, Niho S, Ohe Y, Saijo N, Nishiwaki Y. Yoh K, et al. Among authors: ohmatsu h. J Thorac Oncol. 2010 Sep;5(9):1435-8. doi: 10.1097/JTO.0b013e3181e369a8. J Thorac Oncol. 2010. PMID: 20683210 Free article.

2

Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.

Niho S, Ohe Y, Kakinuma R, Kubota K, Matsumoto T, Ohmatsu H, Goto K, Nishiwaki Y. Niho S, et al. Among authors: ohmatsu h. Lung Cancer. 2002 Feb;35(2):209-14. doi: 10.1016/s0169-5002(01)00328-2. Lung Cancer. 2002. PMID: 11804695 Clinical Trial.

3

Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.

Yoh K, Goto K, Ishii G, Niho S, Ohmatsu H, Kubota K, Kakinuma R, Nagai K, Suga M, Nishiwaki Y. Yoh K, et al. Among authors: ohmatsu h. Cancer. 2003 Sep 1;98(5):926-31. doi: 10.1002/cncr.11606. Cancer. 2003. PMID: 12942558 Free article.

4

Cushing's syndrome associated with adenocarcinoma of the lung.

Yoh K, Kubota K, Nomura M, Niho S, Goto K, Ohmatsu H, Kakinuma R, Nishiwaki Y. Yoh K, et al. Among authors: ohmatsu h. Intern Med. 2003 Sep;42(9):831-3. doi: 10.2169/internalmedicine.42.831. Intern Med. 2003. PMID: 14518671 Free article.

5

Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.

Niho S, Ohe Y, Goto K, Ohmatsu H, Matsumoto T, Kubota K, Kakinuma R, Nishiwaki Y. Niho S, et al. Among authors: ohmatsu h. Jpn J Clin Oncol. 2004 Feb;34(2):69-73. doi: 10.1093/jjco/hyh019. Jpn J Clin Oncol. 2004. PMID: 15067098 Clinical Trial.

6

High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.

Yoh K, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, Nishiwaki Y. Yoh K, et al. Among authors: ohmatsu h. Jpn J Clin Oncol. 2004 Apr;34(4):206-9. doi: 10.1093/jjco/hyh029. Jpn J Clin Oncol. 2004. PMID: 15121757

7

Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?

Minami H, Ohe Y, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, Nishiwaki Y, Nokihara H, Sekine I, Saijo N, Hanada K, Ogata H. Minami H, et al. Among authors: ohmatsu h. J Clin Oncol. 2004 Jul 15;22(14):2901-8. doi: 10.1200/JCO.2004.10.163. J Clin Oncol. 2004. PMID: 15254059 Clinical Trial.

8

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.

Niho S, Kubota K, Goto K, Yoh K, Ohmatsu H, Kakinuma R, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: ohmatsu h. J Clin Oncol. 2006 Jan 1;24(1):64-9. doi: 10.1200/JCO.2005.02.5825. J Clin Oncol. 2006. PMID: 16382114 Clinical Trial.

9

Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs.

Niho S, Goto K, Yoh K, Kim YH, Ohmatsu H, Kubota K, Saijo N, Nishiwaki Y. Niho S, et al. Among authors: ohmatsu h. Jpn J Clin Oncol. 2006 May;36(5):269-73. doi: 10.1093/jjco/hyl021. Epub 2006 May 15. Jpn J Clin Oncol. 2006. PMID: 16702163

10

Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.

Yoh K, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, Saijo N, Nishiwaki Y. Yoh K, et al. Among authors: ohmatsu h. Lung Cancer. 2007 Mar;55(3):337-41. doi: 10.1016/j.lungcan.2006.10.016. Epub 2006 Nov 28. Lung Cancer. 2007. PMID: 17126951 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters